401 related articles for article (PubMed ID: 15918296)
41. Early decrease in nasal eosinophil proportion after nasal allergen challenge correlates with baseline bronchial reactivity to methacholine in children sensitized to house dust mites.
Silvestri M; Battistini E; Defilippi AC; Sabatini F; Sale R; Pecora S; Rossi GA
J Investig Allergol Clin Immunol; 2005; 15(4):266-76. PubMed ID: 16433208
[TBL] [Abstract][Full Text] [Related]
42. [Correlation of serum eosinophil cationic protein with the severity of allergic rhinitis in childhood].
Zhu XJ; Lu MP; Chen RX; Zhu LP; Qi QH; Yin M; Cheng L
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Aug; 47(8):628-32. PubMed ID: 23141391
[TBL] [Abstract][Full Text] [Related]
43. Role of sphingosine 1-phosphate receptor expression in eosinophils of patients with allergic rhinitis, and effect of topical nasal steroid treatment on this receptor expression.
Mackle T; Gendy SS; Walsh M; McConn-Walsh R; Costello RW; Walsh MT
J Laryngol Otol; 2008 Dec; 122(12):1309-17. PubMed ID: 18808729
[TBL] [Abstract][Full Text] [Related]
44. [Diagnostic significance of serum allergen detection in diagnosis of allergic rhinitis and bronchial asthma].
Fan CH; Yang TS; Tang SM; Wang Q; Zhang Z
Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(48):3422-4. PubMed ID: 19159574
[TBL] [Abstract][Full Text] [Related]
45. Prevention of new sensitizations by specific immunotherapy in children with rhinitis and/or asthma monosensitized to house dust mite.
Inal A; Altintas DU; Yilmaz M; Karakoc GB; Kendirli SG; Sertdemir Y
J Investig Allergol Clin Immunol; 2007; 17(2):85-91. PubMed ID: 17460946
[TBL] [Abstract][Full Text] [Related]
46. Eosinophils, specific hyperreactivity and occurrence of late phase reaction in allergic rhinitis.
Milanese M; Ricca V; Canonica GW; Ciprandi G
Eur Ann Allergy Clin Immunol; 2005 Jan; 37(1):7-10. PubMed ID: 15745370
[TBL] [Abstract][Full Text] [Related]
47. Effects of omalizumab, a humanized monoclonal anti-IgE antibody, on nasal reactivity to allergen and local IgE synthesis.
Corren J; Diaz-Sanchez D; Saxon A; Deniz Y; Reimann J; Sinclair D; Davancaze T; Adelman D
Ann Allergy Asthma Immunol; 2004 Sep; 93(3):243-8. PubMed ID: 15478383
[TBL] [Abstract][Full Text] [Related]
48. A double-blind, placebo-controlled study of house dust mite immunotherapy in Chinese asthmatic patients.
Wang H; Lin X; Hao C; Zhang C; Sun B; Zheng J; Chen P; Sheng J; Wu A; Zhong N
Allergy; 2006 Feb; 61(2):191-7. PubMed ID: 16409195
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of an intranasal house dust mite provocation model as a tool in clinical research.
Oldenbeuving NB; KleinJan A; Mulder PG; Lumley P; de Groot EJ; van Drunen CM; Fokkens WJ
Allergy; 2005 Jun; 60(6):751-9. PubMed ID: 15876304
[TBL] [Abstract][Full Text] [Related]
50. Efficacy and safety of specific immunotherapy to mosquito bites.
Ariano R; Panzani RC
Eur Ann Allergy Clin Immunol; 2004 Apr; 36(4):131-8. PubMed ID: 15180354
[TBL] [Abstract][Full Text] [Related]
51. Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trial.
Senti G; Johansen P; Haug S; Bull C; Gottschaller C; Müller P; Pfister T; Maurer P; Bachmann MF; Graf N; Kündig TM
Clin Exp Allergy; 2009 Apr; 39(4):562-70. PubMed ID: 19226280
[TBL] [Abstract][Full Text] [Related]
52. A comparative study of the clinical efficacy of immunotherapy and conventional pharmacological treatment for patients with perennial allergic rhinitis.
Ohashi Y; Nakai Y; Tanaka A; Kakinoki Y; Washio Y; Yamada K; Sakamoto H; Nasako Y; Hayashi M; Nakai Y
Acta Otolaryngol Suppl; 1998; 538():102-12. PubMed ID: 9879409
[TBL] [Abstract][Full Text] [Related]
53. Nasal conditioning in perennial allergic rhinitis after nasal allergen challenge.
Rozsasi A; Leiacker R; Keck T
Clin Exp Allergy; 2004 Jul; 34(7):1099-104. PubMed ID: 15248856
[TBL] [Abstract][Full Text] [Related]
54. Effects of TNFalpha on the human nasal mucosa in vivo.
Widegren H; Korsgren M; Andersson M; Greiff L
Respir Med; 2007 Sep; 101(9):1982-7. PubMed ID: 17532197
[TBL] [Abstract][Full Text] [Related]
55. Comparison of allergen-induced late inflammatory reactions in the nose and in the skin in house dust mite-allergic patients with or without asthma.
Lopuhaä CE; de Riemer MJ; Out TA; Sjamsoedin DH; Aalberse RC; Jansen HM; van der Zee JS
Int Arch Allergy Immunol; 2003 Apr; 130(4):266-74. PubMed ID: 12740527
[TBL] [Abstract][Full Text] [Related]
56. Effect of Dermatophagoides specific immunotherapy on cutaneous reactivity.
Loureiro G; Tavares B; Chieira C; Pereira C
Eur Ann Allergy Clin Immunol; 2007 Jan; 39(1):5-8. PubMed ID: 17375734
[TBL] [Abstract][Full Text] [Related]
57. Evaluation of immunotherapy by nasal antigen challenge.
Cengizlier R; Saraçlar Y; Tomaç N
J Otolaryngol; 1999 Aug; 28(4):185-8. PubMed ID: 10461254
[TBL] [Abstract][Full Text] [Related]
58. Evaluation of serum s-IgE/total IgE ratio in predicting clinical response to allergen-specific immunotherapy.
Di Lorenzo G; Mansueto P; Pacor ML; Rizzo M; Castello F; Martinelli N; Ditta V; Lo Bianco C; Leto-Barone MS; D'Alcamo A; Di Fede G; Rini GB; Ditto AM
J Allergy Clin Immunol; 2009 May; 123(5):1103-10, 1110.e1-4. PubMed ID: 19356792
[TBL] [Abstract][Full Text] [Related]
59. Cluster immunotherapy with a glutaraldehyde-modified mixture of grasses results in an improvement in specific nasal provocation tests in less than 2.5 months of treatment.
Subiza J; Feliú A; Subiza JL; Uhlig J; Fernández-Caldas E
Clin Exp Allergy; 2008 Jun; 38(6):987-94. PubMed ID: 18445082
[TBL] [Abstract][Full Text] [Related]
60. Potential adjuvant effects of Nigella sativa seeds to improve specific immunotherapy in allergic rhinitis patients.
Işik H; Cevikbaş A; Gürer US; Kiran B; Uresin Y; Rayaman P; Rayaman E; Gürbüz B; Büyüköztürk S
Med Princ Pract; 2010; 19(3):206-11. PubMed ID: 20357504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
